Payment overview · 2025
General Payments
4 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · TEXARKANA, TX · NPI 1669467056
Verified facts
CMS Open Payments records show James Randall Sarrett, MD received $74.63 in general payments during 2025 across 4 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $74.63 | 100.0% | 4 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $74.63 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $74.63 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 660 | 188 |
| Amlodipine Besylate | Amlodipine Besylate | 580 | 171 |
| Gabapentin | Gabapentin | 420 | 96 |
| Levothyroxine Sodium | Levothyroxine Sodium | 417 | 100 |
| Losartan Potassium | Losartan Potassium | 407 | 102 |
| Lisinopril | Lisinopril | 372 | 112 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 84 |
| Metformin Hcl Er | Metformin Hcl | 301 | 80 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 253 | 72 |
| Hydrochlorothiazide | Hydrochlorothiazide | 246 | 65 |
| Escitalopram Oxalate | Escitalopram Oxalate | 244 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 244 | 62 |
| Omeprazole | Omeprazole | 242 | 70 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 239 | 89 |
| Glimepiride | Glimepiride | 222 | 57 |
| Potassium Chloride | Potassium Chloride | 220 | 59 |
| Pravastatin Sodium | Pravastatin Sodium | 220 | 60 |
| Furosemide | Furosemide | 211 | 58 |
| Carvedilol | Carvedilol | 201 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 188 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 174 | 49 |
| Eliquis | Apixaban | 173 | 34 |
| Sertraline Hcl | Sertraline Hcl | 167 | 34 |
| Simvastatin | Simvastatin | 162 | 46 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 160 | 39 |
| Tramadol Hcl | Tramadol Hcl | 159 | 44 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 158 | 47 |
| Meloxicam | Meloxicam | 151 | 39 |
| Jardiance | Empagliflozin | 139 | 27 |
| Ozempic | Semaglutide | 137 | 23 |
| Chlorthalidone | Chlorthalidone | 113 | 28 |
| Allopurinol | Allopurinol | 112 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 109 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 103 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 102 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 99 | 26 |
| Finasteride | Finasteride | 94 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 89 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 21 |
| Metformin Hcl | Metformin Hcl | 87 | 25 |
| Warfarin Sodium | Warfarin Sodium | 86 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 85 | 20 |
| Celecoxib | Celecoxib | 84 | 25 |
| Alendronate Sodium | Alendronate Sodium | 73 | 17 |
| Atenolol | Atenolol | 73 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 73 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 72 | 15 |
| Lorazepam | Lorazepam | 69 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | 16 |
| Ezetimibe | Ezetimibe | 64 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 64 | 13 |
| Prednisone | Prednisone | 61 | 48 |
| Trazodone Hcl | Trazodone Hcl | 61 | 18 |
| Alprazolam | Alprazolam | 60 | 22 |
| Bupropion Xl | Bupropion Hcl | 60 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 19 |
| Valsartan | Valsartan | 57 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 49 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 49 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 45 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 44 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 15 |
| Pregabalin | Pregabalin | 43 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 41 | suppressed |
| Nifedipine Er | Nifedipine | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 39 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 39 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 39 | suppressed |
| Azithromycin | Azithromycin | 38 | 24 |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 38 | suppressed |
| Clonazepam | Clonazepam | 37 | 11 |
| Naproxen | Naproxen | 37 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 36 | suppressed |
| Xarelto | Rivaroxaban | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 33 | 12 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Ramipril | Ramipril | 31 | suppressed |
| Sotalol | Sotalol Hcl | 31 | suppressed |
| Methylprednisolone | Methylprednisolone | 28 | 27 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Verapamil Er | Verapamil Hcl | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Spironolactone | Spironolactone | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 20 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 22 | suppressed |
| Indapamide | Indapamide | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 18 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Repatha Syringe | Evolocumab | 16 | suppressed |
| Telmisartan | Telmisartan | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Livalo | Pitavastatin Calcium | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Nabumetone | Nabumetone | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Nexletol | Bempedoic Acid | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 11 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $74.63 · 4 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error